These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18461136)

  • 41. Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis.
    Bartolucci P; Brugnara C; Teixeira-Pinto A; Pissard S; Moradkhani K; Jouault H; Galacteros F
    Blood; 2012 Oct; 120(15):3136-41. PubMed ID: 22919030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis.
    Deonikar P; Kavdia M
    J Appl Physiol (1985); 2012 Apr; 112(8):1383-92. PubMed ID: 22223452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lactate dehydrogenase and hemolysis in sickle cell disease.
    Ballas SK
    Blood; 2013 Jan; 121(1):243-4. PubMed ID: 23287628
    [No Abstract]   [Full Text] [Related]  

  • 44. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
    Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
    Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
    Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
    Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia.
    Maier-Redelsperger M; Lévy P; Lionnet F; Stankovic K; Haymann JP; Lefèvre G; Avellino V; Perol JP; Girot R; Elion J
    Blood Cells Mol Dis; 2010 Dec; 45(4):289-92. PubMed ID: 20833087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laboratory and echocardiography markers in sickle cell patients with leg ulcers.
    Minniti CP; Taylor JG; Hildesheim M; O'Neal P; Wilson J; Castro O; Gordeuk VR; Kato GJ
    Am J Hematol; 2011 Aug; 86(8):705-8. PubMed ID: 21630312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial Nitric Oxide Synthase (eNOS) Gene Polymorphisms and Markers of Hemolysis, Inflammation and Endothelial Dysfunction in Brazilian Sickle Cell Anemia Patients.
    Chenou F; Albuquerque DM; Leonardo DP; Domingos IF; Bezerra MAC; Araújo AS; Blotta MHSL; Costa FF; Sonati MF; Paula EV; Santos MNN
    Biochem Genet; 2020 Aug; 58(4):580-594. PubMed ID: 32277314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Chenou F; Hounkpe BW; Domingos IF; Tonassé WV; Batista THC; Santana RM; Arcanjo GDS; Alagbe AE; Araújo ADS; Lucena-Araújo AR; Bezerra MAC; Costa FF; Sonati MF; De Paula EV; Dos Santos MNN
    Ann Hematol; 2021 Nov; 100(11):2669-2676. PubMed ID: 34453189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.
    Machado RF; Anthi A; Steinberg MH; Bonds D; Sachdev V; Kato GJ; Taveira-DaSilva AM; Ballas SK; Blackwelder W; Xu X; Hunter L; Barton B; Waclawiw M; Castro O; Gladwin MT;
    JAMA; 2006 Jul; 296(3):310-8. PubMed ID: 16849664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha thalassemia protects sickle cell anemia patients from macro-albuminuria through its effects on red blood cell rheological properties.
    Lamarre Y; Romana M; Lemonne N; Hardy-Dessources MD; Tarer V; Mougenel D; Waltz X; Tressières B; Lalanne-Mistrih ML; Etienne-Julan M; Connes P
    Clin Hemorheol Microcirc; 2014; 57(1):63-72. PubMed ID: 24004554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
    Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
    Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pain in sickle cell disease. Rates and risk factors.
    Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
    N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Albuminuria, serum antioxidant enzyme levels and markers of hemolysis and inflammation in steady state children with sickle cell anemia.
    Itokua KE; Makulo JR; Lepira FB; Aloni MN; Ekulu PM; Sumaili EK; Bukabau JB; Mokoli VM; Longo AL; Kajingulu FM; Zinga CV; Nlandu YM; Engole YM; Akilimali PZ; Ngiyulu RM; Gini JL; Nseka NM
    BMC Nephrol; 2016 Nov; 17(1):178. PubMed ID: 27855647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment dilemmas: strategies for priapism, chronic leg ulcer disease, and pulmonary hypertension in sickle cell disease.
    Azbell RCG; Desai PC
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):411-417. PubMed ID: 34889382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature.
    Haymann JP; Stankovic K; Levy P; Avellino V; Tharaux PL; Letavernier E; Grateau G; Baud L; Girot R; Lionnet F
    Clin J Am Soc Nephrol; 2010 May; 5(5):756-61. PubMed ID: 20185605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease.
    Zhou Z; Yee DL; Guchhait P
    Curr Vasc Pharmacol; 2012 Nov; 10(6):756-61. PubMed ID: 22272904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
    Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
    N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemoglobin sickle cell disease complications: a clinical study of 179 cases.
    Lionnet F; Hammoudi N; Stojanovic KS; Avellino V; Grateau G; Girot R; Haymann JP
    Haematologica; 2012 Aug; 97(8):1136-41. PubMed ID: 22315500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease.
    Baldanzi G; Traina F; Marques Neto JF; Santos AO; Ramos CD; Saad ST
    Clinics (Sao Paulo); 2011; 66(5):801-5. PubMed ID: 21789383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.